- Posted June 06, 2014
- Tweet This | Share on Facebook
Michigan, 43 states settle with GlaxoSmithKline
LANSING (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.
Michigan Attorney General Bill Schuette announced Wednesday that Michigan's share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn't been approved by the Food and Drug Administration.
GSK is prohibited from disseminating information that describes any so-called off-label use.
The asthma drug Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressants.
Published: Fri, Jun 06, 2014
headlines Oakland County
- Historical: Circuit Court judge has made indelible mark
- ABA amicus brief supports noncitizens’ right to a bond hearing when detention becomes ‘unreasonably prolonged’
- Nessel secures full victory in lawsuit challenging administration’s attack on fair housing protections
- Whitmer announces new automotive jobs, investment in Oakland County
- AG pushes federal government to strengthen rules to combat illegal robocalls
headlines National
- Lindsay Clancy trial shows how hard it is to prove intent retroactively
- Is there a religious right to abortion? State supreme court will weigh in
- Harvey raises $550M in latest round of funding
- Vanderbilt law students will gain access to AI-powered deposition simulations
- Federal judges’ interns may accept stipends from law firms, ethics panel says
- Former lawyer who pulled gun on ex-wife in restaurant convicted of attempted murder
